A newly surfaced internal memo from the U.S. Food and Drug Administration (FDA) has sparked debate after chief medical and scientific officer Vinay Prasad stated that COVID-19 vaccinations may have contributed to at least 10 cases of fatal heart inflammation in children. According to the memo, seen by Reuters, Prasad said the staff’s preliminary review suggested “likely, probable, or possible” vaccine attribution in these deaths. He described the findings as significant, noting it would mark the first time the FDA acknowledged potential fatal vaccine-related cases in American children.
The analysis reviewed 96 child deaths reported between 2021 and 2024. While it did not identify the children’s underlying medical conditions or the vaccine manufacturers involved, Prasad said that the early assessment found no fewer than 10 cases potentially linked to COVID-19 vaccination. He added that examining deaths involving children aged 7 to 16 was especially difficult.
Health Secretary Robert F. Kennedy Jr. has recently shifted U.S. vaccine policy, restricting access to COVID-19 vaccines to individuals 65 and older and those with certain conditions. Kennedy, long known for his skepticism toward vaccines, has criticized past vaccine policies promoted under both the Trump and Biden administrations.
Experts have urged caution in interpreting the memo. The FDA’s assessment has not been peer-reviewed or published in a medical journal, and critics—including UC Law San Francisco professor Dorit Reiss—argue that policy changes should not stem from unpublished investigations. Reiss also noted Prasad is not a vaccine specialist.
Despite concerns raised in the memo, FDA Commissioner Marty Makary emphasized that COVID-19 vaccines were highly effective for older adults, especially when matched to circulating variants. Recent research also supports the benefits of updated vaccines in reducing severe illness and hospitalization among high-risk groups.
CDC data shows 1,071 U.S. children aged 5 to 18 died from COVID-19 between early 2020 and mid-2023. Prasad argued that it remains unclear how vaccination influenced those outcomes, stating that voluntary reporting and unknown prevention metrics complicate comparisons.
The memo is expected to fuel continued discussion ahead of an upcoming CDC vaccine committee meeting.


Israel Receives Body of Deceased Hostage as Rafah Crossing Reopening Hinges on Final Returns
New Orleans Immigration Crackdown Sparks Fear as Federal Arrests Intensify
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
Apple Alerts EU Regulators That Apple Ads and Maps Meet DMA Gatekeeper Thresholds
U.S. Officials Say Afghan Suspect in D.C. National Guard Shooting Radicalized After Arrival
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
Germany Moves to Approve €2.9 Billion Defense Procurement Package
Trump Administration Halts Immigration, Green Card, and Citizenship Processing for 19 Countries
Trump Administration Tightens H-1B Visa Vetting With New Focus on Free Speech and Censorship
Trump Pardons Former Honduran President Juan Orlando Hernández in Controversial Move
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
U.S. Soybean Shipments to China Gain Momentum as Trade Tensions Ease
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement
U.S. Repatriation Flight Carrying 266 Venezuelan Migrants Lands in Caracas
Maduro Confirms “Respectful” Call With Trump, Signals Openness to Diplomatic Dialogue
Australia Moves Forward With Teen Social Media Ban as Platforms Begin Lockouts 



